Obsessive–compulsive spectrum of disorders: a defensible construct?

References

• Bebbington P. Epidemiology of obsessive–compulsive disorder. British Journal of Psychiatry 1998; 173(Suppl 35)2–6
   Google Scholar
• Robins L N, Helzer J E, Weissman M M, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry 1984; 41: 958–967
   Google Scholar
• Myers J K, Weissman M M, Tischler G L, et al. Six month prevalence of psychiatric disorders in three communities, 1980 to 1982. Archives of General Psychiatry 1984; 41: 949–958
   PubMed Web of Science ®Google Scholar
• Flament M F, Koby E, Rapaport J L, et al. Childhood obsessive–compulsive disorder: a prospective follow-up study. Journal of Child Psychology and Psychiatry 1990; 31: 363–380
   PubMed Web of Science ®Google Scholar
• Bland R C, Newman S C, Orn H. Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatrica Scandinavica 1988; 77(Suppl 1)33–42
   Google Scholar
• Zohar A H, Ratoni G, Pauls D L, et al. An epidemiological study of obsessive–compulsive disorder and related disorders in Israeli adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1992; 31: 1057–1061
   PubMed Web of Science ®Google Scholar
• Angst A. The epidemiology of obsessive compulsive disorder. Current insights in obsessive compulsive disorder, E Hollander, J Zohar, D Marazziti, et al. Wiley, West SussexUK 1994; 93–104
   Google Scholar
• Weissman M M, Bland R C, Canino G L, et al. The cross-national epidemiology of obsessive–compulsive disorder. Journal of Clinical Psychiatry 1994; 55: 5–10
   PubMed Web of Science ®Google Scholar
• Hollander E. Obesessive–compulsive spectrum disorders: an overview. Psychiatric Annals 1993; 23: 355–358
   Web of Science ®Google Scholar
• Rasmussen S A. Obsessive compulsive spectrum disorders. Journal of Clinical Psychiatry 1994; 55: 89–91
   PubMed Web of Science ®Google Scholar
• Leckman J F, Zhang H, Alsobrook J P, et al. Symptom dimensions in obsessive–compulsive disorder: towards quantitative phenotypes. American Journal of Medical Genetics 2001; 105: 28–30
   PubMed Web of Science ®Google Scholar
• Cochran L W, Smith M J, Greenberg B D, et al. Factor analysis of symptoms in obsessive–compulsive disorder. Presented at the 5th International Obsessive Compulsive Disorder Conference, SardiniaItaly, 2001, 29 March–1 April
   Google Scholar
• Mataix-Cols D, Rauch S L, Baer L, et al. Symptom stability in adult obsessive–compulsive disorder: data from a naturalistic two-year follow-up study. American Journal of Psychiatry 2002; 159: 263–268
   PubMed Web of Science ®Google Scholar
• Keuneman R J, Pokos V, Weerasundera R, Castle D J. Antipsychotic treatment in obsessive-compulsive disorder: a literature review. Australian and New Zealand Journal of Psychiatry 2005; 39: 336–343
   PubMed Web of Science ®Google Scholar
• Swedo S E, Leondard H L, Mittleman B B, et al. Identification of children with paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a market associated with rheumatic fever. American Journal of Psychiatry 1997; 154: 110–112
   PubMed Web of Science ®Google Scholar
• Blanes T, McGuire P. Heterogeneity within obsessive–compulsive disorder: evidence for primary and neurodevelopmental subtypes. Neurodevelopment and adult psychopathology, M S Keshavan, R M Murray. Cambridge University Press, CambridgeUK 1997; 206–212
   Google Scholar
• Murray R M, O’Callaghan E, Castle D J, Lewis S W. A neurodevelopmental approach to the classification of schizophrenia. Schizophrenia Bulletin 1992; 319–332
   PubMedGoogle Scholar
• Saxena S, Brody A L, Schwartz J M, Baxter L R. Neuroimaging and frontal–subcortical circuitry in obsessive–compulsive disorder. British Journal of Psychiatry 1998; 173(Suppl 35)26–37
   Google Scholar
• McElroy S L, Phillips K A, Keck P E, Jr. Obsessive–compulsive spectrum disorders. Journal of Clinical Psychiatry 1994; 55: 33–51
   PubMed Web of Science ®Google Scholar
• Hollander E. Introduction. Obsessive–compulsive related disorders, E Hollander. American Psychiatric Press, Washington, DC 1993; 1–16
   Google Scholar
• Cohen L J, Stein D J, Simeon D, . Obsessive–compulsive spectrum disorders. Obsessive–compulsive disorders, E Hollander, D J Stein, et al. Marcel Dekker, New York 1997; 47–74
   Google Scholar
• Hollander E. Treatment of obsessive–compulsive spectrum disorders with SSRIs. British Journal of Psychiatry 1998; 173(Suppl 35)7–12
   Google Scholar
• Phillips K A, Price L H, Greenberg B D, Rasmussen S A. Should DSM's diagnostic groupings be changed?. Advancing DSM: dilemmas in psychiatric diagnosis, K A Phillips, M B First, H Pincus. American Psychiatric Press, Washington, DC 2005; 57–84
   Google Scholar
• Hyman S. Foreward. Advancing DSM: dilemmas in psychiatric diagnosis, K A Phillips, M B First, H Pincus. American Psychiatric Press, Washington, DC 2005; xi–xxi
   Google Scholar
• Phillips K A, McElroy S L, Keck P E, Jr, Pope H G, Jr, Hudson J I. Body dysmorphic disorder: 30 cases of imagined ugliness. American Journal of Psychiatry 1993; 150: 302–308
   PubMed Web of Science ®Google Scholar
• Crino R. Obsessive–compulsive spectrum disorders: are opposites related?. Obsessive compulsive disorder, M Maj, N Sartorius, A Okasha, J Zohar. Wiley, Chichester 2000; 246–249
   Google Scholar
• Eisen J L, Phillips K A, Rasmussen S A. Obsessions and delusions: the relationship between obsessive compulsive disorder and the psychotic disorders. Psychiatric Annals 1999; 29: 515–522
   Google Scholar
• Phillips K A, McElroy S L, Keck P E, Jr, Pope H G, Jr, Hudson J I. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacological Bulletin 1994; 30: 179–186
   PubMedGoogle Scholar
• Phillips K A, McElroy S L, Hudson J I, Pope H G, Jr. Body dysmorphic disorder: an obsessive compulsive spectrum disorder, a form of affective spectrum disorder, or both?. Journal of Clinical Psychiatry 1995; 56: 41–52
   PubMed Web of Science ®Google Scholar
• Veale D. Cognitive behaviour therapy for body dysmorphic disorder. Disorders of body image, D J Castle, K A Phillips. Wrightson Biomedical Publishing, PetersfieldUK 2002; 121–138
   Google Scholar
• Barsky A J. Hypochondriasis and obsessive–compulsive disorder. Psychiatric Clinics of North America 1992; 15: 791–801
   PubMed Web of Science ®Google Scholar
• Fallon B A, Qureshi A I, Laje G, Klein B. Hypochondriasis and its relationship to obsessive–compulsive disorder. Psychiatric Clinics of North America 2000; 23: 605–616
   PubMedGoogle Scholar
• Fallon B A, Javitch J A, Hollander E, Liebowitz M R. Hypochondriasis and obsessive compulsive disorder: overlaps in diagnosis and treatment. Journal of Clinical Psychiatry 1991; 52: 457–460
   PubMed Web of Science ®Google Scholar
• O'sullivan R L, Mansueto C S, Lerner E A, Miguel E C. Characterisation of trichotillomania. Psychiatric Clinics of North America 2000; 23: 587–604
   PubMed Web of Science ®Google Scholar
• Phillips K A, Gunderson C G, Mallya G, McElroy S L, Carter W. A comparison study of body dysmorphic disorder and obsessive compulsive disorder. Journal of Clinical Psychiatry 1998; 59: 568–575
   PubMed Web of Science ®Google Scholar
• Phillips K A, Diaz S. Gender differences in body dysmorphic disorder. Journal of Nervous and Mental Disease 1997; 185: 570–577
   PubMed Web of Science ®Google Scholar
• Magarinos M, Zafar U, Nissenson K, Blanco C. Epidemiology and treatment of hypochondriasis. CNS Drugs 2002; 16: 9–22
   PubMed Web of Science ®Google Scholar
• Horwarth E, Weissman M M. The epidemiology and cross-national presentation of obsessive compulsive disorder. Psychiatric Clinics of North America 2000; 23: 493–507
   PubMedGoogle Scholar
• Skoog G, Skoog I. A 40-year follow-up of patients with obsessive–compulsive disorder. Archives of General Psychiatry 1999; 56: 121–127
   PubMed Web of Science ®Google Scholar
• Noyes R, Jr, Kathol R G, Fisher M M, Phillips B M, Suelzer M T, Woodman C L. Psychiatric comorbidity among patients with hypochondriasis. General Hospital Psychiatry 1994; 16: 78–87
   Google Scholar
• Barsky A J, Fama J M, Bailey E D, et al. A prospective 4- to 5-year study of DSM-III-R hypochondriasis. Archives of General Psychiatry 1998; 55: 737–744
   PubMedGoogle Scholar
• Foa E B, Franklin M E. Psychotherapies for obsessive–compulsive disorder: a review. Obsessive compulsive disorder, R Crino, M Maj, N Sartorius, A Okasha, J Zohar. Wiley, Chichester 2000; 93–115
   Google Scholar
• Zohar J, Sasson Y, Chopra M, Amital D, Iancu I. Pharmacological treatment of obsessive–compulsive disorder: a review. Obsessive–Compulsive Disorder 2000; 43–61
   Google Scholar
• Hood S, Alderton D, Castle D. Obsessive–compulsive disorder: treatment and treatment resistance. Australasian Psychiatry 2001; 19: 118–127
   Google Scholar
• Jenike M A. An update on obsessive–compulsive disorder. Bulletin of the Menninger Clinic 2001; 65: 4–25
   PubMedGoogle Scholar
• Stein D J. Neurobiology of the obsessive–compulsive spectrum disorders. Biological Psychiatry 2000; 47: 296–304
   PubMed Web of Science ®Google Scholar
• Phillips K A, Albertini R S, Rasmussen S A. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Archives of General Psychiatry 2002; 59: 381–388
   PubMed Web of Science ®Google Scholar
• Hollander E, Allen A, Kwon J, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Archives of General Psychiatry 1999; 56: 1033–1039
   PubMed Web of Science ®Google Scholar
• Hadley S, Newcorn J H, Hollander E. The neurobiology and psychopharmacology of body dysmorphic disorder. Disorders of body image, D J Castle, K A Phillips. Wrightson Biomedical Publishing, PetersfieldUK 2002; 139–155
   Google Scholar
• Fallon B A, Liebowitz M R, Salman E, et al. Fluoxetine for hypochondriacal patients without major depression. Journal of Clinical Psychopharmacology 1993; 13: 438–441
   PubMed Web of Science ®Google Scholar
• Oosterbaan D B, Van Balkom A JLM, Van Boeijen C A, De Meij T GJ, Van Dyck R. An open study of paroxetine in hypochondriasis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2001; 25: 1023–1033
   PubMed Web of Science ®Google Scholar
• Pilkowsky I. The response to treatment in hypochondriacal disorders. Australian and New Zealand Journal of Psychiatry 1968; 2: 88–94
   Google Scholar
• Fallon B A, Feinstein S. Hypochondriasis. Somatoform and factitious disorders, K A Phillips. American Psychiatric Press, Washington, DC 2001; 27–60, (Review of Psychiatry Series, Vol 20, No 3; Oldham JM and Riba MB., series editors)
   Google Scholar
• Swedo S E, Leonard H L, Rapoport J L, et al. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). New England Journal of Medicine 1989; 321: 497–501
   PubMed Web of Science ®Google Scholar
• Streichenwein S M, Thornby J I. A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. American Journal of Psychiatry 1995; 152: 1192–1196
   PubMed Web of Science ®Google Scholar
• Christenson G A, Mackenzie T B, Mitchell J E, Mitchell J E, Callies A L. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. American Journal of Psychiatry 1991; 148: 1566–1571
   PubMed Web of Science ®Google Scholar
• Christenson G A, Crow S J. The characterization and treatment of trichotillomania. Journal of Clinical Psychiatry 1996; 57: 42–49
   PubMed Web of Science ®Google Scholar
• Pollard C A, Ibe I O, Krojanker D N, Kitchen A D, Bronson S S, Flynn T M. Clomipramine treatment of trichotillomania: a follow-up report on four cases. Journal of Clinical Psychiatry 1991; 52: 128–139
   PubMed Web of Science ®Google Scholar
• Kellner R. The prognosis of treated hypochondriasis: a clinical study. Acta Psychiatrica Scandinavica 1983; 67: 69–79
   PubMed Web of Science ®Google Scholar
• Rauch S L, Dougherty D D, Shin L M, et al. Neural correlates of factor-analyzed OCD symptom dimensions: a PET study. CNS Spectrums 1998; 3: 37–43
   Google Scholar
• Bienvenu O J, Samuels J F, Riddle M A, et al. The relationship of obsessive–compulsive disorder to possible spectrum mechanisms: results from a family study. Biological Psychiatry 2000; 48: 287–293
   PubMed Web of Science ®Google Scholar
• Noyes R, Jr, Holt C S, Happel R L, Kathol R G, Yagla S J. A family study of hypochondriasis. Journal of Nervous and Mental Disease 1997; 185: 223–232
   PubMedGoogle Scholar
• King R A, Scahill L, Vitulano L A, et al. Childhood trichotillomania: clinical phenomenology, comorbidity, and family genetics. Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34: 1451–1459
   PubMed Web of Science ®Google Scholar
• Lenane M C, Swedo S E, Rapoport J L, et al. Rates of obsessive compulsive disorder in first degree relatives of patients with trichotillomania: a research note. Journal of Child Psychology and Psychiatry 1992; 33: 925–933
   PubMed Web of Science ®Google Scholar
• Okasha A. Diagnosis of obsessive compulsive disorder: a review. Obsessive compulsive disorder, M Maj, N Sartorius, A Okasha, J Zohar. Wiley, Chichester 2000; 1–19
   Google Scholar
• Barsky A J, Wyshak G, Klerman G L. Hypochondriasis: an evaluation of the DSM-III criteria in medical outpatients. Archives of General Psychiatry 1986; 43: 493–500
   PubMed Web of Science ®Google Scholar
• Tyrer P, Lee I, Alexander J. Awareness of cardiac function in anxious, phobic, and hypochondriacal patients. Psychological Medicine 1980; 10: 171–174
   PubMedGoogle Scholar
• Eriksson E, Hedberg M A, Andersch B, Sundblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharamacology 1995; 12: 167–176
   PubMed Web of Science ®Google Scholar
• Rauch S L, Baxter L R, Jr. Neuroimaging in obsessive–compulsive disorder and related disorders. Obsessive compulsive disorders: practical management 3rd edn., M J Jenike, L Baer, W E Minichiello. Mosby, St Louis, MO 1998; 289–317
   Google Scholar
• Pato M T, Pato C N, Pauls D L. Recent findings in the genetics of OCD. Journal of Clinical Psychiatry 2002; 63: 30–33
   PubMedGoogle Scholar
• Marazziti D, Gemignani A, Dell’Osso L. Trazodone augmentation in OCD: a case series report. CNS Spectrums 1999; 4: 48–49
   PubMedGoogle Scholar
• Kim S W, Grant J E. An open naltrexone treatment study in pathological gambling disorder. International Clinical Psychopharmacology 2001; 16: 285–289
   PubMed Web of Science ®Google Scholar